CTOs on the Move

WISDOM TRADITIONS COUNSELING SERVICES

www.awisdomcenter.com

 
Wisdom Traditions is an Integrative Healthcare Center located in Anchorage Alaska. Specializing in Mind/Body approaches, we offer a variety of services ranging from acupuncture, physical therapy and manual medicine to professional counseling, life c...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

TubeWriter

TubeWriter is a company that provides direct labeling systems and services to the life sciences industry. Their solutions print on any laboratory tube, slide or plate, and offer superior durability of print at extreme temperatures, up to 90% reduction ...

The Buckeye Ranch

Restoring hope and providing healing services for children and families in Central and Southwestern Ohio - from mental health treatment to foster care.

GenRx Pharmacy

Welcome to GenRx Pharmacy in Scottsdale, AZ. Visit our website for our location, information and new patient sign ups.

BPR-Bechtel

BPR-Bechtel is a Sherbrooke, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Respira Therapeutics

Respira Therapeutics, Inc., founded in 2010 with offices in Albuquerque, New Mexico, is a development stage inhaled pharmaceutical development company focused on commercializing its "best in class", high efficiency AOS-DPI, dry powder inhaler (DPI) drug delivery technology to deliver RT234, a proprietary inhaled formulation of an off patent oral drug via the lung to treatment of multiple orphan indications in the fields of pulmonary hypertension and other diseases. Investors in Respira include Cottonwood Technology Fund and Sun Mountain Capital and individual investors. To date Respira has performed extensive testing demonstrating its advanced AOS-DPI prototypes can deliver 2-3X more drug to the lung than commercially available DPI technologies. Respira is planning proof of concept clinical trials of an inhaled formulation of RT234 in pulmonary arterial hypertension patients in the near future.